Coadministration of oral cyclosporin A enables oral therapy with paclitaxel.

J M Meerum Terwogt(The Netherlands Cancer Institute), J.H.M. Schellens, Francisca J Koopman, Marius Swart, Hilde Rosing(The Netherlands Cancer Institute), M M Malingré, W W ten Bokkel Huinink, J. H. Beijnen, Olaf van Tellingen(Dutch Cancer Society)

PubMed

November 1, 1999

Cited by 206

Related Papers

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

|Cell|1994|2.3k

Overcoming the blood–brain tumor barrier for effective glioblastoma treatment

|Drug Resistance Updates|2015|1k

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins

|Proceedings of the National Academy of Sciences|1997|941

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

|Proceedings of the National Academy of Sciences|1997|884

Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.

|PubMed|2002|688